198 related articles for article (PubMed ID: 29845425)
1. A Novel PET Probe "[
Shimizu Y; Zhao S; Yasui H; Nishijima KI; Matsumoto H; Shiga T; Tamaki N; Ogawa M; Kuge Y
Mol Imaging Biol; 2019 Feb; 21(1):122-129. PubMed ID: 29845425
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
3. FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
Masaki Y; Shimizu Y; Yoshioka T; Nishijima KI; Zhao S; Higashino K; Numata Y; Tamaki N; Kuge Y
Ann Nucl Med; 2017 Oct; 31(8):596-604. PubMed ID: 28695498
[TBL] [Abstract][Full Text] [Related]
4. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
Shimizu Y
Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
6. Eribulin improves tumor oxygenation demonstrated by
Bo T; Yasui H; Shiga T; Shibata Y; Fujimoto M; Suzuki M; Higashikawa K; Miyamoto N; Inanami O; Kuge Y
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):821-833. PubMed ID: 34468781
[TBL] [Abstract][Full Text] [Related]
7. Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia.
Masaki Y; Shimizu Y; Yoshioka T; Feng F; Zhao S; Higashino K; Numata Y; Kuge Y
PLoS One; 2016; 11(8):e0161639. PubMed ID: 27580239
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
[TBL] [Abstract][Full Text] [Related]
10. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
11. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
[TBL] [Abstract][Full Text] [Related]
12. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of gallium-68-labeled nitroimidazole-based imaging probes for PET diagnosis of tumor hypoxia.
Shimizu Y; Nakai Y; Iikuni S; Watanabe H; Nakamoto Y; Ono M
Ann Nucl Med; 2021 Mar; 35(3):360-369. PubMed ID: 33423155
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and radiation dosimetry of the novel hypoxia PET probe [
Watanabe S; Shiga T; Hirata K; Magota K; Okamoto S; Toyonaga T; Higashikawa K; Yasui H; Kobayashi J; Nishijima KI; Iseki K; Matsumoto H; Kuge Y; Tamaki N
EJNMMI Res; 2019 Jul; 9(1):60. PubMed ID: 31278504
[TBL] [Abstract][Full Text] [Related]
15. The accumulation mechanism of the hypoxia imaging probe "FMISO" by imaging mass spectrometry: possible involvement of low-molecular metabolites.
Masaki Y; Shimizu Y; Yoshioka T; Tanaka Y; Nishijima K; Zhao S; Higashino K; Sakamoto S; Numata Y; Yamaguchi Y; Tamaki N; Kuge Y
Sci Rep; 2015 Nov; 5():16802. PubMed ID: 26582591
[TBL] [Abstract][Full Text] [Related]
16. Development of Novel
Wang L; Wang H; Shen K; Park H; Zhang T; Wu X; Hu M; Yuan H; Chen Y; Wu Z; Wang Q; Li Z
J Med Chem; 2021 May; 64(9):5593-5602. PubMed ID: 33901402
[TBL] [Abstract][Full Text] [Related]
17. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
Solomon B; Binns D; Roselt P; Weibe LI; McArthur GA; Cullinane C; Hicks RJ
Mol Cancer Ther; 2005 Sep; 4(9):1417-22. PubMed ID: 16170034
[TBL] [Abstract][Full Text] [Related]
20. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
Busk M; Horsman MR; Jakobsen S; Hansen KV; Bussink J; van der Kogel A; Overgaard J
Radiother Oncol; 2009 Sep; 92(3):429-36. PubMed ID: 19729214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
